2026 NPPES data Pulmonary Disease Physician NPI 1407295686 M.D.
Verify on CMS →

NATALIA LOUREIRO, M.D.

Pulmonary Disease Physician in PALMETTO BAY, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
557
Medicare Part D claims · 99 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
32%
generic claims · 68% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
30.2422/100
▼ 53 pts below national avg 83.1 · [object Object]
Industry payments
$777.19
26 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NATALIA LOUREIRO, M.D. reported a CMS MIPS final score of 30.2422/100 — below the 83.1 national average — and filed 557 Medicare Part D claims in 2023.

30.2422/100
MIPS score · -53 vs avg
557
Part D claims, 2023
32%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NATALIA LOUREIRO, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

30 3rd percentile higher than 3% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). This entry sits in this band. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NATALIA LOUREIRO, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NATALIA LOUREIRO, M.D.?

Below national average

NPI registry status

Active

Issued 06/20/2013

NPI 1407295686

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

557 62% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

30.2422/100 52.8578% pts

Below average band

vs 83.1 national avg

Specialty distribution in Florida

How Pulmonary Disease Physician compares to other specialties among Florida providers

Florida providers

Pulmonary Disease Physician share within Florida

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Florida

Medicare quality performance — MIPS

NATALIA LOUREIRO, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

Below national average
MIPS Final Score
30.2422/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 30.2422/100 vs national avg 83.1

0%100%National avg83%30.2%
MIPS final score (Pulmonary Disease Physician) — 30.2422/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NATALIA LOUREIRO, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 9299 CORAL REEF DR STE 203, PALMETTO BAY, FL, 33157, with a listed phone of (305) 234-9180. NPI 1407295686 was issued on 06/20/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOUREIRO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 557 prescription claims written by this provider, covering 99 Medicare beneficiaries and totaling roughly $262K in drug spend, split 68% brand-name and 32% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 30.2422/100 for the 2023 performance year (Quality 30, Cost 27.474), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9299 CORAL REEF DR STE 203
PALMETTO BAY, FL 33157

Provider Details

NPI 1407295686
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Female
NPI Issued 06/20/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

30.2422
Final Score
Avg: 83.1
30
Quality
27.474
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where NATALIA LOUREIRO, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PRAGER SIMON AND ASSOCIATES LLP
PALMETTO BAY, FL
PROFESSIONAL HEALTHCARE ASSOCIATES LLC
PALMETTO BAY, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NATALIA LOUREIRO, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$777

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to NATALIA LOUREIRO, M.D.. To verify NATALIA LOUREIRO, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

NATALIA LOUREIRO, M.D. — brand share 68.0%
Specialty average (est.)

68% brand-name claims vs 32% generic, on 557 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

557
Total Claims
$262K
Total Drug Cost
99
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
676
Total Day Supply
19,383
Brand vs Generic
68% brand / 32% generic
Brand Drug Cost
$258K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.80
Gender Split
72% female / 28% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NATALIA LOUREIRO, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
118
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
105
Symbicort
Budesonide/Formoterol Fumarate
64
Montelukast Sodium
50
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
47
Fluticasone-Salmeterol
Fluticasone Propion/Salmeterol
21
Budesonide-Formoterol Fumarate
Budesonide/Formoterol Fumarate
20
Prednisone
19
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
14
Dupixent Pen
Dupilumab
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How NATALIA LOUREIRO, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

NATALIA LOUREIRO, M.D.'s 557 claims are below the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as LOUREIRO.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NATALIA LOUREIRO, M.D.'s specialty?
NATALIA LOUREIRO, M.D. specializes in Pulmonary Disease Physician and practices in PALMETTO BAY, Florida. Credentials: M.D..
How much does NATALIA LOUREIRO, M.D. prescribe under Medicare Part D?
In 2023, NATALIA LOUREIRO, M.D. wrote 557 Medicare Part D claims totaling $262K in drug costs for 99 beneficiaries.
What is NATALIA LOUREIRO, M.D.'s Medicare quality score?
NATALIA LOUREIRO, M.D. has a CMS MIPS Final Score of 30.2422/100 (Quality: 30, Cost: 27.474). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NATALIA LOUREIRO, M.D. located?
NATALIA LOUREIRO, M.D. is located at 9299 CORAL REEF DR STE 203, PALMETTO BAY, FL, 33157. Phone: (305) 234-9180.
What is NATALIA LOUREIRO, M.D.'s NPI number?
NATALIA LOUREIRO, M.D.'s National Provider Identifier (NPI) is 1407295686, issued on 06/20/2013.
Does NATALIA LOUREIRO, M.D. prescribe more brand-name or generic drugs?
NATALIA LOUREIRO, M.D.'s prescribing is 68% brand-name and 32% generic drugs by claim count, with $258K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does NATALIA LOUREIRO, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NATALIA LOUREIRO, M.D.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Trelegy Ellipta, Symbicort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NATALIA LOUREIRO, M.D. accept Medicare?
NATALIA LOUREIRO, M.D. appears in CMS Medicare data with 557 Part D claims and 99 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NATALIA LOUREIRO, M.D.'s credentials?
NATALIA LOUREIRO, M.D.'s NPI is 1407295686 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology